Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

February 28, 2025

Conditions
Type 2 DiabetesAcute Myocardial InfarctionAcute Myocardial Infarction With ST ElevationDiabetes Complications
Interventions
DEVICE

Dexcom ONE Continuous Glucose Monitoring System

The Dexcom ONE is comprised of a sensor, transmitter and display device (receiver and/or compatible smart device). The system features a redesigned, one-touch auto-applicator and sleek, discreet transmitter. CGM involves insertion of a small plastic cannula to the subcutaneous tissue of the abdominal skin by members of the study team. The cannula is attached to a small data. The cannula is attached to a small transmitter which is taped to the skin and sends data about interstitial glucose via Bluetooth to a receiver which displays a blood glucose reading. The Dexcom G6 sends glucose readings to a compatible smart device or the Dexcom receiver every 5 minutes.

Trial Locations (1)

Unknown

RECRUITING

Hammersmith Hospital inpatient cardiology services, London

All Listed Sponsors
lead

Imperial College London

OTHER